{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":1498,"total_is_capped":false,"direct_labels_cover":9,"predictions_cover":1498,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"adb06e8f08bc","filters":{"topic":"Antiplatelet Therapy and Cardiovascular Diseases"}},"results":[{"id":"W1553345686","doi":"10.1056/nejmoa010746","title":"Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation","year":2001,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":6486,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Population Health Research Institute; Hamilton General Hospital","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Placebo; Internal medicine; Myocardial infarction; Relative risk; Stroke (engine); Acute coronary syndrome; Confidence interval; Cardiology; Anesthesia; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.006613261563669518,"gpt":0.240237507539794,"spread":0.2336242459761245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003902136,0.0001292518,0.0005664701,0.0003607374,0.00001162621,0.000002118321,0.00005949404,0.00004790042,0.0000726811],"category_scores_gemma":[0.00008563422,0.0000822347,0.00006682055,0.0003092091,0.00003836117,0.00009782642,0.000008409404,0.00018288,0.000001246559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007788309,"about_ca_system_score_gemma":0.000101141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003188455,"about_ca_topic_score_gemma":0.00001893483,"domain_scores_codex":[0.9985977,0.00009296556,0.0004406784,0.0001127473,0.0006064195,0.0001494466],"domain_scores_gemma":[0.9992956,0.00007907529,0.0001932926,0.000109085,0.0001394665,0.0001834663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01098279,0.0003804167,0.7613707,0.0001013422,0.0003967218,0.001296912,0.0004023118,0.0001064315,0.0005192279,0.000006450822,0.0003305745,0.2241061],"study_design_scores_gemma":[0.08904196,0.006323935,0.898827,0.002579798,0.0003321047,0.0005272778,0.00005684027,0.000007078094,0.0002088244,0.00003957293,0.001979461,0.00007617113],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967215,0.001006285,0.001052203,0.0006167091,0.0001290313,0.0004240143,0.000002837746,0.000004864084,0.00004254682],"genre_scores_gemma":[0.9981852,0.0007709552,0.0003078289,0.0003271384,0.0003152891,0.000003957474,0.00003049081,0.0000135676,0.00004560471],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2240299,"threshold_uncertainty_score":0.3353434,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100209149","doi":"10.1056/nejmoa060989","title":"Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events","year":2006,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2827,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Aspirin; Clopidogrel; Cardiology; Platelet aggregation inhibitor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02727216451352251,"gpt":0.296974711625172,"spread":0.2697025471116495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008512093,0.0001136677,0.0004872995,0.00007958739,0.00004608525,0.000003024378,0.00007554924,0.00005047321,0.00005180228],"category_scores_gemma":[0.0001194025,0.00006231626,0.0002259615,0.00009454116,0.0001127527,0.00005099085,0.000009883051,0.0001312827,6.374306e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000178308,"about_ca_system_score_gemma":0.00009065935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005603421,"about_ca_topic_score_gemma":0.00001757604,"domain_scores_codex":[0.9988986,0.00006430199,0.0004301533,0.00009140433,0.0003874692,0.0001280634],"domain_scores_gemma":[0.9990525,0.0002710635,0.0002759866,0.0001498779,0.0001458577,0.0001046623],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01731187,0.0004258594,0.02069288,0.0004747512,0.002895333,0.00009585942,0.0004745794,0.0002481171,0.008105157,0.0007730367,0.004419348,0.9440832],"study_design_scores_gemma":[0.5012369,0.01858225,0.3051802,0.003471475,0.007809612,0.002266595,0.0006403036,0.0002315401,0.003463188,0.007183952,0.1496112,0.0003227885],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628264,0.02460751,0.00875896,0.002692857,0.0005249828,0.0003776961,0.000002354239,0.00000667629,0.0002025986],"genre_scores_gemma":[0.9945536,0.00169829,0.0004455831,0.00009212817,0.002827974,0.000002401149,0.000007036241,0.00001509956,0.0003578796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9437604,"threshold_uncertainty_score":0.2541183,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162886638","doi":"10.1016/s0140-6736(01)05701-4","title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","year":2001,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2808,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Conventional PCI; Medicine; Clopidogrel; Percutaneous coronary intervention; Myocardial infarction; Aspirin; Internal medicine; Cardiology; Clinical endpoint; Acute coronary syndrome; Thienopyridine; Placebo; Surgery; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.009913633990753016,"gpt":0.2497653634566191,"spread":0.2398517294658661,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001661561,0.0001386469,0.0003641974,0.00002080173,0.00006450847,0.00001370642,0.0001110443,0.00003066787,0.00001657971],"category_scores_gemma":[0.000009329462,0.00006582345,0.0001043801,0.0001023015,0.00008513808,0.00003393338,0.00002745798,0.0001075448,0.000001452432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003731251,"about_ca_system_score_gemma":0.00001599621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002490573,"about_ca_topic_score_gemma":0.00006269031,"domain_scores_codex":[0.9990879,0.0002093179,0.000140383,0.000166478,0.0002372273,0.0001587124],"domain_scores_gemma":[0.9994226,0.000120158,0.00006089379,0.0003386048,0.00002502473,0.00003270441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004435448,0.00134674,0.9681277,0.00009542504,0.0009365769,0.0004034633,0.0006983236,0.000003507792,0.000042165,0.000003830174,0.000118647,0.02378823],"study_design_scores_gemma":[0.0166711,0.00479771,0.977123,0.0003626894,0.0002517333,0.0001994581,0.0003087573,0.000004274422,0.00009554907,0.00001190543,0.0000930907,0.00008069175],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883856,0.009863841,0.00001836476,0.0002157267,0.0000371604,0.00137311,0.000004153204,0.00002051697,0.00008158968],"genre_scores_gemma":[0.9960616,0.003512179,0.000006635855,0.0001897551,0.00005765824,0.00004026732,0.00001711102,0.00001638771,0.00009846027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02370754,"threshold_uncertainty_score":0.2684202,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141358924","doi":"10.1056/nejmoa1500857","title":"Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1970,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ticagrelor; Term (time); Myocardial infarction; Medicine; Cardiology; Internal medicine; Percutaneous coronary intervention","retraction":null,"screen_n_in":null,"score":{"opus":0.02355036611789261,"gpt":0.2528091807199831,"spread":0.2292588146020905,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004799905,0.0001077609,0.0005313801,0.0002003233,0.0000105671,0.000003980751,0.00005037774,0.00005077657,0.00004291921],"category_scores_gemma":[0.0003094376,0.00006202429,0.0001011234,0.0001682487,0.00009100724,0.0001481108,0.000008674476,0.0001967976,0.000001365596],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004413101,"about_ca_system_score_gemma":0.0002219355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003313032,"about_ca_topic_score_gemma":0.00000694025,"domain_scores_codex":[0.9986125,0.00008428028,0.000398652,0.000082833,0.0007001863,0.0001216104],"domain_scores_gemma":[0.9988964,0.00006099224,0.000213192,0.0001449351,0.0003726837,0.0003118654],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009736594,0.0001585663,0.8415199,0.000028461,0.0004273258,0.0001712853,0.0004404504,0.0000475,0.00005239954,0.000005278381,0.0005933639,0.1468189],"study_design_scores_gemma":[0.1060918,0.003419223,0.8851884,0.0005997868,0.0004730291,0.0002885089,0.00004105858,0.000003315485,0.00004827802,0.00001647059,0.003771367,0.00005872925],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973647,0.001109756,0.0004439558,0.0005537368,0.0002731002,0.00016828,0.00000125499,0.000004734334,0.00008050562],"genre_scores_gemma":[0.9981155,0.0002619039,0.0001934928,0.000198273,0.001158324,4.283698e-7,0.000008818845,0.00001262924,0.00005061049],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1467602,"threshold_uncertainty_score":0.2529277,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147800731","doi":"10.1378/chest.11-2298","title":"Perioperative Management of Antithrombotic Therapy","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1641,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; Sanofi; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Pfizer","keywords":"Medicine; Antithrombotic; Perioperative; Warfarin; Atrial fibrillation; Vitamin K antagonist; Guideline; Surgery; Thrombosis; Bridging (networking); Stent; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.0313881980672498,"gpt":0.2908428595477427,"spread":0.2594546614804929,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002383,0.00008102041,0.0002115098,0.00003810749,0.00006759405,0.00001105826,0.00004977033,0.00002858822,0.0004845355],"category_scores_gemma":[0.000003258228,0.00005628527,0.0002437718,0.00007802428,0.00006287838,0.0001125986,0.000009804687,0.0001129073,0.00002497242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002039895,"about_ca_system_score_gemma":0.00002569564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.392616e-7,"about_ca_topic_score_gemma":1.533651e-8,"domain_scores_codex":[0.9993789,0.00003481506,0.0001433477,0.00005680846,0.0002138982,0.0001722025],"domain_scores_gemma":[0.999613,0.00000581438,0.00005183896,0.0001274622,0.00005717452,0.0001447161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001700027,0.00341644,0.4991508,0.001009242,0.01399081,0.0008953721,0.006679632,0.00004132554,0.03258367,0.004693944,0.001606161,0.4342326],"study_design_scores_gemma":[0.004385774,0.0002851633,0.9225868,0.0002541831,0.0003504861,0.001553682,0.001976276,0.000005968641,0.02039919,0.000035445,0.04802126,0.0001458085],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9715555,0.02176951,0.00107528,0.0001027534,0.0001814669,0.0001162142,7.45358e-7,0.00001021903,0.005188335],"genre_scores_gemma":[0.9877684,0.01012603,0.00136366,0.0001204415,0.000302313,0.000002023186,0.000001689821,0.00001190897,0.0003035788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4340868,"threshold_uncertainty_score":0.5305324,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2099409915","doi":"10.1161/circulationaha.106.612812","title":"Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1341,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Acute coronary syndrome; Unstable angina; Stroke (engine); Incidence (geometry); Clopidogrel; Proportional hazards model; Antithrombotic; Diabetes mellitus; Cardiology; Angina; Aspirin; Myocardial infarction; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.008928021555640786,"gpt":0.239138606642039,"spread":0.2302105850863982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004534805,0.00007810327,0.0001716294,0.00009929452,0.0000182618,0.000002361114,0.00001833526,0.00003929018,0.00003137207],"category_scores_gemma":[0.000003831285,0.00005918003,0.0001444839,0.0001583346,0.00002262757,0.00008385017,0.000003397065,0.0000413522,0.000004008794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007788087,"about_ca_system_score_gemma":0.00003374515,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000319768,"about_ca_topic_score_gemma":8.107105e-7,"domain_scores_codex":[0.9994354,0.00001640783,0.0001240768,0.0001171716,0.0002123303,0.00009463903],"domain_scores_gemma":[0.9997613,0.000009305341,0.00005346978,0.00009709589,0.00005190626,0.00002695827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006319711,0.0002835861,0.99392,0.0000218674,0.0002948845,0.00003714185,0.00002507077,0.002422828,0.0001909396,0.00002250898,0.00001002625,0.002139122],"study_design_scores_gemma":[0.00283898,0.0003352122,0.9960775,0.0001463512,0.000176,0.00001523141,0.000009976435,0.0001627728,0.0001482167,0.0000233588,0.000002253923,0.00006419676],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991979,0.00007497403,0.00004430946,0.000006199528,0.00001539358,0.0003508714,0.000007298756,0.00001950055,0.0002835625],"genre_scores_gemma":[0.9997607,0.000006491328,0.00003003248,0.000007828023,0.00001773859,0.000007993586,0.0001521963,0.00001145427,0.000005581647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002260055,"threshold_uncertainty_score":0.2413292,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147195562","doi":"10.1161/01.cir.0000013777.21160.07","title":"Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1053,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton Health Sciences; Princess Margaret Cancer Centre; Hamilton General Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Quartile; Odds ratio; Thromboxane; Population; Confidence interval; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.01529250480078735,"gpt":0.2115288534859925,"spread":0.1962363486852051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001301504,0.0002687488,0.001055195,0.0001681618,0.0002595716,0.00001508533,0.00009709811,0.0001759625,0.00004628866],"category_scores_gemma":[0.0004613618,0.0001863968,0.002474376,0.0002719498,0.0001553618,0.0001267747,0.00004597796,0.0001504148,0.000006986707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001592825,"about_ca_system_score_gemma":0.00002779575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004997458,"about_ca_topic_score_gemma":0.00001593909,"domain_scores_codex":[0.9973,0.0005865221,0.000514119,0.0004858123,0.0008200425,0.0002935369],"domain_scores_gemma":[0.9983507,0.0002280755,0.0002133287,0.000877339,0.0002280631,0.0001025331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002610158,0.0001864218,0.9402831,0.0001697736,0.01750699,0.000005415609,0.000232259,0.00539478,0.00003778985,0.00007352247,0.00002373414,0.03347602],"study_design_scores_gemma":[0.01688684,0.0001386352,0.9716268,0.00008877612,0.007565027,0.00001052872,0.00004532487,0.0009768775,0.0001730425,0.0002172395,0.002058412,0.0002125666],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816734,0.01405075,0.001900873,0.00003019779,0.0001663204,0.001899836,0.0001839681,0.00003571052,0.0000589128],"genre_scores_gemma":[0.9933097,0.006065516,0.0001652402,0.00002997367,0.0001617987,0.0001214352,0.00007979931,0.00004464571,0.00002187397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03326345,"threshold_uncertainty_score":0.7601039,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2976166882","doi":"10.1056/nejmoa1908419","title":"Ticagrelor with or without Aspirin in High-Risk Patients after PCI","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1000,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; University Health Network","funders":"Janssen Pharmaceuticals; Abbott Vascular; St. Jude Medical; MicroPort; Idorsia Pharmaceuticals; PharmaMar; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; British Heart Foundation; Sanofi; Abiomed; Osprey Medical; Amarin Pharma; Novo Nordisk; Medicines Company; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Massachusetts Medical Society; Regeneron Pharmaceuticals; Medicure; US WorldMeds; Bristol-Myers Squibb; Eli Lilly and Company; Pfizer; Icahn School of Medicine at Mount Sinai; CSL Behring; Cardinal Health; Amgen","keywords":"Ticagrelor; Conventional PCI; Percutaneous coronary intervention; Aspirin; P2Y12; Medicine; Cardiology; Internal medicine; Clopidogrel; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.006067489123158599,"gpt":0.2275467937173601,"spread":0.2214793045942015,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005098372,0.0001670445,0.0007312066,0.0001951533,0.0000146927,0.000005677731,0.00008324459,0.00006287867,0.0008909351],"category_scores_gemma":[0.0001166231,0.00008042857,0.0001047746,0.0001919692,0.00006869481,0.00009949106,0.00001143581,0.0003705592,0.00002598731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003892741,"about_ca_system_score_gemma":0.0001784594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009005374,"about_ca_topic_score_gemma":0.0000512087,"domain_scores_codex":[0.9984727,0.0001009911,0.0004159109,0.000145581,0.0006637145,0.0002011152],"domain_scores_gemma":[0.9990196,0.00008786524,0.0002121646,0.000217774,0.0001673549,0.0002952482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01894398,0.0001272016,0.8373649,0.00005496225,0.00034351,0.0006191113,0.0003855874,0.0000184622,0.0000299593,0.000004970338,0.0003255124,0.1417819],"study_design_scores_gemma":[0.2093899,0.008262461,0.7499459,0.001702917,0.0007081651,0.0008133718,0.0001756545,0.00001855598,0.00006572129,0.0000613301,0.02871008,0.0001460135],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966003,0.001568265,0.0001872062,0.0007067614,0.0002981042,0.000267442,0.000002114154,0.000008453575,0.0003614005],"genre_scores_gemma":[0.9962502,0.0007109923,0.0003364293,0.0006377129,0.001287364,0.000001727649,0.000005250969,0.00002442342,0.0007458883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1904459,"threshold_uncertainty_score":0.9755115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2397867274","doi":"10.1056/nejmoa0805002","title":"Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":966,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Population Health Research Institute; Boehringer Ingelheim (Canada)","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Dipyridamole; Clopidogrel; Aspirin; Medicine; Stroke (engine); Ticlopidine; Cardiology; Internal medicine; Anesthesia; Physics","retraction":null,"screen_n_in":null,"score":{"opus":0.03448034004767551,"gpt":0.2930483216181666,"spread":0.258567981570491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004622617,0.0001608412,0.0005778968,0.0001413014,0.00008456199,0.000004369446,0.00007215272,0.0000618831,0.00008499712],"category_scores_gemma":[0.000337073,0.0001055459,0.0002487831,0.00008237315,0.0001659578,0.00007207364,0.00001258931,0.000237636,0.0000019392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002891037,"about_ca_system_score_gemma":0.0001936821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001024166,"about_ca_topic_score_gemma":0.000003789624,"domain_scores_codex":[0.9987444,0.0000529538,0.0003984775,0.0001447023,0.0004585125,0.000200914],"domain_scores_gemma":[0.9987643,0.0001946503,0.0001792032,0.0001613755,0.0001924413,0.0005080621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02863632,0.0002067782,0.0034939,0.0001257459,0.00104687,0.001062864,0.0005488354,0.00001118138,0.001051759,0.0001603803,0.0134406,0.9502147],"study_design_scores_gemma":[0.367224,0.02203238,0.03909697,0.0009197998,0.002008106,0.01027912,0.0004081469,0.0001079627,0.0008165853,0.000359243,0.5564639,0.0002837669],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9526423,0.04001318,0.002679007,0.002805103,0.001040835,0.0002463301,0.000008293574,0.0000163538,0.000548613],"genre_scores_gemma":[0.9824318,0.01035784,0.0007312488,0.0003633347,0.005605622,0.00000261634,0.00001052371,0.0000213686,0.0004756992],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.949931,"threshold_uncertainty_score":0.4304036,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2142021807","doi":"10.1056/nejmoa1200933","title":"Vorapaxar in the Secondary Prevention of Atherothrombotic Events","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Secondary prevention; Medicine; Business; Cardiology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0245095231994228,"gpt":0.2954160606448997,"spread":0.2709065374454769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002023631,0.00008733672,0.0004223573,0.0001188779,0.00001672969,0.000001234624,0.00009824825,0.00004246898,0.0003449779],"category_scores_gemma":[0.0001350022,0.00004501757,0.0001927971,0.0001571779,0.00005992854,0.0001064225,0.000006163604,0.0002478047,0.000002542754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001666238,"about_ca_system_score_gemma":0.0001066387,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001627108,"about_ca_topic_score_gemma":0.000003014474,"domain_scores_codex":[0.9986848,0.0002257846,0.0004168893,0.00004877499,0.0004826067,0.0001411299],"domain_scores_gemma":[0.9993285,0.00009952691,0.0002257806,0.0001522932,0.00006553034,0.0001283776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002117831,0.0007857411,0.1897571,0.0002307245,0.0009550541,0.0001542115,0.008275909,0.00001506222,0.004284437,0.0003038828,0.003407498,0.7897125],"study_design_scores_gemma":[0.07959303,0.002716045,0.8544536,0.00156219,0.001068427,0.003867146,0.001861693,0.00000488457,0.0005728227,0.001691665,0.05250334,0.0001051815],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773306,0.0192853,0.0006429139,0.001424391,0.0003114862,0.0001558138,5.555017e-7,0.000002620083,0.0008462815],"genre_scores_gemma":[0.9960309,0.001181161,0.000124214,0.0003323725,0.00221012,7.213016e-7,0.00000253444,0.00000856916,0.0001094574],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7896073,"threshold_uncertainty_score":0.3777266,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2109577952","doi":"10.1056/nejmoa1205512","title":"Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":871,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta","funders":"Genentech; Servier; Astellas Pharma; Regado Biosciences; Medicines Company; Amarin Corporation; Eisai; Boston VA Research Institute; Boston Scientific Corporation; Helsinn; Janssen Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Pfizer; Daiichi Sankyo Europe; Sanofi; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Prasugrel; Clopidogrel; Medicine; Cardiology; Internal medicine; Revascularization; Acute coronary syndrome; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.03414270373853988,"gpt":0.3242639092236171,"spread":0.2901212054850772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009991971,0.0001707331,0.0006645081,0.0001456155,0.00006396012,0.000005827296,0.00009122014,0.000092954,0.0001456397],"category_scores_gemma":[0.0003383265,0.0001106784,0.0003362037,0.0001370592,0.00008726037,0.000200111,0.00001150144,0.0002061514,0.000004641608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000483599,"about_ca_system_score_gemma":0.0001633842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005009998,"about_ca_topic_score_gemma":7.186933e-7,"domain_scores_codex":[0.9985453,0.00008194762,0.0004318742,0.0001096288,0.0005632536,0.0002680293],"domain_scores_gemma":[0.9986672,0.000156281,0.0002546249,0.0002041561,0.0002437845,0.0004739692],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04336213,0.000529597,0.1770794,0.0003508845,0.01671023,0.0006251929,0.002203747,0.00005388535,0.004438973,0.0009803553,0.02601157,0.727654],"study_design_scores_gemma":[0.3919385,0.009848516,0.1472786,0.001368833,0.01626757,0.02122681,0.0005023668,0.00008773369,0.0007461869,0.0003712037,0.4099494,0.0004142647],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9131123,0.04201648,0.03656996,0.003947476,0.003112367,0.0005923744,0.000006243067,0.00003693186,0.0006058537],"genre_scores_gemma":[0.9847113,0.004663303,0.002215176,0.0004711356,0.007335809,0.000003979364,0.00003522824,0.00003405243,0.0005299772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7272397,"threshold_uncertainty_score":0.4513334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144206796","doi":"10.1016/s0140-6736(10)61088-4","title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":824,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Population Health Research Institute; Université de Montréal; Montreal Heart Institute; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Percutaneous coronary intervention; Aspirin; Conventional PCI; Loading dose; Maintenance dose; Myocardial infarction; Randomized controlled trial; Internal medicine; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.0431597706418513,"gpt":0.3324374110726355,"spread":0.2892776404307842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001171619,0.0004745569,0.001435183,0.0001700726,0.0002565924,0.000129724,0.0003744659,0.0002653799,0.0001604756],"category_scores_gemma":[0.0002968066,0.0003642275,0.0007377756,0.0002098698,0.000284655,0.0002462012,0.0001593284,0.0007101971,0.00001551513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001489662,"about_ca_system_score_gemma":0.0003069769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005919641,"about_ca_topic_score_gemma":0.0001977459,"domain_scores_codex":[0.9971096,0.0003089501,0.0006549393,0.0006154267,0.0006437898,0.0006673298],"domain_scores_gemma":[0.9975178,0.001107742,0.0002574245,0.0007814086,0.0001031778,0.0002325072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9397684,0.0004591462,0.001448868,0.0002757638,0.003004484,0.000385054,0.0005085808,0.00001455851,0.0006105003,0.0002397186,0.0008486182,0.05243625],"study_design_scores_gemma":[0.9719093,0.004969009,0.01272233,0.0004333412,0.002529244,0.0004948907,0.0003294845,0.0000708174,0.0001948426,0.0004172898,0.005406726,0.0005227572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845612,0.002852543,0.00008069373,0.0004201268,0.007591531,0.003788542,0.0004941014,0.0001454865,0.00006577422],"genre_scores_gemma":[0.9938737,0.002510449,0.0002471847,0.00006674448,0.002346244,0.0002811914,0.000513388,0.00007765485,0.00008345705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0519135,"threshold_uncertainty_score":0.999881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076482318","doi":"10.1016/j.jacc.2007.03.025","title":"Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":804,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"Sanofi","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Internal medicine; Hazard ratio; Stroke (engine); Placebo; Cardiology; Population; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.007646570878303793,"gpt":0.2463419721057281,"spread":0.2386954012274243,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009633197,0.0001674413,0.0009738124,0.000142709,0.00008342641,0.000007271733,0.0002858342,0.00004711162,0.00001429943],"category_scores_gemma":[0.0002463852,0.00007638683,0.0007924818,0.000402818,0.0005143085,0.00007214997,0.0000308651,0.0002726879,6.275888e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008496322,"about_ca_system_score_gemma":0.0004544772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006091062,"about_ca_topic_score_gemma":0.000003538693,"domain_scores_codex":[0.9977801,0.0005537678,0.0006161841,0.00013289,0.0006596805,0.0002573502],"domain_scores_gemma":[0.9984064,0.0002033663,0.0006385567,0.0003839027,0.0002402633,0.0001274982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4813873,0.0004216592,0.5071035,0.00004127544,0.003016687,0.0007948855,0.0002512331,0.0003873934,0.0001673596,0.00003801749,0.001386235,0.00500439],"study_design_scores_gemma":[0.04174715,0.003603122,0.9474361,0.00007019119,0.0008959961,0.0005333187,0.0007696534,0.000006517771,0.00001732691,0.00002390466,0.004789318,0.0001074069],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973086,0.0001546924,0.0003295944,0.0005971561,0.0006748147,0.0007623099,0.00005276764,0.000004975959,0.00011512],"genre_scores_gemma":[0.9979545,0.0000829722,0.00009714003,0.0005030185,0.001301089,0.000009408698,0.000002568991,0.00001626759,0.00003299099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4403326,"threshold_uncertainty_score":0.3114965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2973068166","doi":"10.1161/circulationaha.119.040167","title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; 123 Certification (Canada)","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Abbott Vascular; St. Jude Medical; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Gilead Sciences; Servier; Eisai; Sanofi; Abiomed; Osprey Medical; Chiesi USA; Claret Medical; Biosense Webster; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Cook Medical; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Abbott Laboratories; CSL Behring; University of Florida; B. Braun Melsungen; Amgen; Pfizer; Medicure","keywords":"Medicine; Percutaneous coronary intervention; Clinical trial; Population; Guideline; Regulatory affairs; Intensive care medicine; Medical emergency; Myocardial infarction; Internal medicine; Environmental health; Pathology; Public administration","retraction":null,"screen_n_in":null,"score":{"opus":0.02278705769970059,"gpt":0.2842924585683699,"spread":0.2615054008686693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002757273,0.0002876848,0.001148435,0.000296347,0.00006624123,0.00002836759,0.00007243595,0.0003092851,0.00008875618],"category_scores_gemma":[0.0001152456,0.0002736701,0.0009791533,0.0002455015,0.00001935301,0.0001217677,0.00003465508,0.0003592618,0.0001917484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004310808,"about_ca_system_score_gemma":0.0001316421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002361277,"about_ca_topic_score_gemma":0.000003197128,"domain_scores_codex":[0.9982423,0.0002233708,0.0005709715,0.0004212174,0.0003250543,0.0002171554],"domain_scores_gemma":[0.9990732,0.0001323127,0.0003539092,0.0003206379,0.00005854632,0.00006138026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00004439623,0.00009931953,0.06109117,0.009754096,0.0005161474,0.00005463282,0.00003258359,0.0001208774,9.593644e-8,0.00006863977,0.000007091668,0.928211],"study_design_scores_gemma":[0.01165019,0.0007472305,0.6282678,0.1856657,0.02210251,0.001610174,0.0002077628,0.0007210931,5.502293e-7,0.0003655346,0.1466272,0.002034292],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.05878717,0.939403,0.0001910373,0.000001336565,0.0003883278,0.0009494648,0.00002143449,0.00005831087,0.0001998996],"genre_scores_gemma":[0.3030477,0.6954888,0.0000415967,0.00000865328,0.0000703352,0.00001396947,0.001259517,0.00005133928,0.00001816528],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9261767,"threshold_uncertainty_score":0.9999716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2888458270","doi":"10.1016/s0140-6736(18)31858-0","title":"Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":785,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier; Abbott Vascular; Regeneron Pharmaceuticals; Daiichi Sankyo Europe; Sanofi; University of Bern; Amarin Corporation; Boston Scientific Corporation; Amgen; Pfizer; Biosensors International Group; Canada Research Chairs; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ticagrelor; Medicine; Aspirin; Clopidogrel; Percutaneous coronary intervention; Acute coronary syndrome; Coronary artery disease; Myocardial infarction; Internal medicine; Clinical endpoint; Cardiology; Randomized controlled trial","retraction":null,"screen_n_in":null,"score":{"opus":0.04259067970504685,"gpt":0.324734246856156,"spread":0.2821435671511091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002708172,0.001172302,0.003843743,0.0001978409,0.0007539653,0.000284352,0.001292429,0.0005620158,0.0000827511],"category_scores_gemma":[0.0007844515,0.0008472165,0.001782734,0.0003294474,0.0004614028,0.0004827688,0.0001422772,0.0003412874,0.0000133366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003602684,"about_ca_system_score_gemma":0.0006188948,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002883304,"about_ca_topic_score_gemma":0.0004650039,"domain_scores_codex":[0.9933085,0.000435055,0.00201274,0.001519363,0.0008365277,0.001887747],"domain_scores_gemma":[0.9936121,0.002600868,0.0009130524,0.00169534,0.0006783552,0.0005003189],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9149109,0.001420275,0.0003614333,0.001075939,0.004810574,0.00001258758,0.002538338,0.00003928668,0.006776986,0.0001126785,0.03643992,0.0315011],"study_design_scores_gemma":[0.8127095,0.009559518,0.0002311622,0.0007203302,0.003732793,0.00001863262,0.000843209,0.02916936,0.01409679,0.0003164091,0.1272554,0.001346977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8528653,0.009723438,0.05833021,0.003560646,0.001667475,0.06584235,0.00745522,0.0003700354,0.0001853005],"genre_scores_gemma":[0.9186174,0.002857544,0.02553265,0.00471391,0.005459819,0.03297605,0.003375071,0.0007977978,0.005669781],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1022014,"threshold_uncertainty_score":0.9993979,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103481781","doi":"10.1503/cmaj.082001","title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada","keywords":"Clopidogrel; Medicine; Myocardial infarction; Pantoprazole; Percutaneous coronary intervention; Internal medicine; Odds ratio; Confidence interval; Population; Cardiology; Proton-pump inhibitor; Concomitant; Omeprazole","retraction":null,"screen_n_in":null,"score":{"opus":0.006796539008106614,"gpt":0.2486483329281494,"spread":0.2418517939200428,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134124,0.00007751861,0.0002236376,0.0001105014,0.0001823946,0.00002645287,0.00006649355,0.0001157158,0.0001343422],"category_scores_gemma":[0.0004848379,0.00005449646,0.0001427648,0.0001803923,0.00001235211,0.00006669632,0.000004044304,0.0004509015,0.000002018747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003149924,"about_ca_system_score_gemma":0.0006884483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001485333,"about_ca_topic_score_gemma":0.002325851,"domain_scores_codex":[0.998266,0.0002240736,0.0003181362,0.00009551716,0.0009381284,0.0001581656],"domain_scores_gemma":[0.9989805,0.00006403095,0.0001919348,0.00009351704,0.0001612068,0.000508835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002075672,0.00007137546,0.9628806,0.0000076793,0.0001441942,0.00002446434,0.0002317352,0.000006052845,0.000002874197,0.000003567814,0.0006293732,0.03597736],"study_design_scores_gemma":[0.00190614,0.0001580035,0.990654,0.0001337621,0.0001417138,0.00003754949,0.0006046481,0.0000504688,0.00005120301,0.00004394779,0.006161388,0.00005719485],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900157,0.0001060559,0.000009819031,0.009128696,0.0001925252,0.0004392751,0.000003952397,0.000007680759,0.00009625654],"genre_scores_gemma":[0.99752,0.0000149222,0.00000575489,0.001732107,0.0006734434,0.000004725066,0.000005998456,0.000005913485,0.00003707693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03592016,"threshold_uncertainty_score":0.2245389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138058610","doi":"10.1161/circulationaha.108.791061","title":"Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38","year":2008,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":757,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Prasugrel; Medicine; Clopidogrel; Internal medicine; TIMI; Myocardial infarction; Cardiology; Diabetes mellitus; Hazard ratio; Stroke (engine); Thrombolysis; Endocrinology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.0357255022373527,"gpt":0.2852329244042375,"spread":0.2495074221668848,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007817455,0.0003424799,0.0009922261,0.0004619129,0.00005431332,0.00002594297,0.00009383102,0.000198801,0.000008212235],"category_scores_gemma":[0.00004532617,0.0002121385,0.0001688482,0.0009324354,0.000160048,0.0003311459,0.00001783738,0.0003801744,0.000001141684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002025869,"about_ca_system_score_gemma":0.0001121302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001975976,"about_ca_topic_score_gemma":0.00009872804,"domain_scores_codex":[0.9971705,0.0003219583,0.0008231655,0.0005401622,0.0007619094,0.0003823263],"domain_scores_gemma":[0.99886,0.0001300024,0.0002747777,0.0003905002,0.0002733649,0.00007133782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02669859,0.0009154211,0.9554157,0.00002467635,0.0004812861,0.00005004721,0.001797328,0.005633873,0.000333782,0.000005579612,0.000003336902,0.008640407],"study_design_scores_gemma":[0.07525276,0.002439264,0.9198921,0.0003411896,0.00009822531,0.00000688723,0.0007974325,0.0002776395,0.0006067369,0.00001637988,0.00000744968,0.0002638755],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958883,0.0002380252,0.0003162078,0.0002812334,0.00006084264,0.003171464,0.00001347161,0.00002006627,0.00001040717],"genre_scores_gemma":[0.9985026,0.0001620072,0.0001176197,0.0007078918,0.00003582252,0.0002064461,0.000222876,0.00004366096,0.000001086226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04855417,"threshold_uncertainty_score":0.8650755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2134322421","doi":"10.1056/nejmoa1109719","title":"Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":753,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Thrombin; Antagonist; Cardiology; Medicine; Internal medicine; Receptor antagonist; Receptor; Pharmacology; Platelet","retraction":null,"screen_n_in":null,"score":{"opus":0.02951225523606125,"gpt":0.2674083577149176,"spread":0.2378961024788564,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006994507,0.0001824265,0.0007929314,0.0002347234,0.00003689657,0.000004426448,0.0001471351,0.000082462,0.001964522],"category_scores_gemma":[0.00007974391,0.0001174702,0.0002371241,0.0002089324,0.0001833442,0.0001281517,0.00001648112,0.0003603938,0.00001683019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004321355,"about_ca_system_score_gemma":0.0002124982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000768036,"about_ca_topic_score_gemma":0.000005799112,"domain_scores_codex":[0.9984731,0.0001049742,0.0005422638,0.0001434408,0.0005049059,0.0002313085],"domain_scores_gemma":[0.9990351,0.00005629981,0.0002058896,0.0002118823,0.0001152998,0.0003755501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02561276,0.001476798,0.399648,0.0002536603,0.007580014,0.03643908,0.009684724,0.00003942048,0.0212619,0.0005038645,0.03293465,0.4645652],"study_design_scores_gemma":[0.2548628,0.01236169,0.5857742,0.002759619,0.003110228,0.07029396,0.001972817,0.00003421088,0.004195476,0.001267847,0.06282429,0.0005428002],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837568,0.01158836,0.0004920738,0.001509855,0.0007717483,0.0001508464,0.000003336867,0.00001725612,0.001709759],"genre_scores_gemma":[0.9902606,0.006590577,0.0009155463,0.0006184558,0.001233492,9.596083e-7,0.000008806886,0.00002425427,0.0003472879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4640223,"threshold_uncertainty_score":0.9989478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988143463","doi":"10.1136/bmj.39430.529549.be","title":"Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis","year":2008,"lang":"en","type":"review","venue":"BMJ","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":705,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Toronto General Hospital; University Health Network","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Odds ratio; Confidence interval; Meta-analysis; Acute coronary syndrome; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.07676824522354753,"gpt":0.3371925302022406,"spread":0.2604242849786931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.001581221,0.0005276261,0.01991459,0.00024694,0.00006862231,0.00001331124,0.0001304918,0.0002128458,0.00006907383],"category_scores_gemma":[0.000290468,0.0003240771,0.0185958,0.0006808973,0.0001531181,0.00004008748,0.00006285037,0.0002424413,0.00001002953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002485642,"about_ca_system_score_gemma":0.0001245758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004107714,"about_ca_topic_score_gemma":0.000004887326,"domain_scores_codex":[0.9959503,0.001306825,0.001274002,0.0005748732,0.000699345,0.0001946891],"domain_scores_gemma":[0.9970055,0.0001747364,0.0007844613,0.001717402,0.0001392265,0.0001786696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000002108201,0.00001372626,0.000002042817,0.4991652,0.4972914,0.00009739896,0.000003742052,4.371287e-7,7.968552e-10,0.000003406052,0.0002713847,0.003149169],"study_design_scores_gemma":[0.0001449343,0.00001420486,0.00000553579,0.03402961,0.6734429,0.0003713541,0.00000344535,3.022313e-7,7.16093e-8,0.000001997474,0.2917952,0.0001904768],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002633727,0.9950346,0.0001183209,0.00002288036,0.00001382929,0.004311365,0.0002197567,0.00002664054,0.0002500009],"genre_scores_gemma":[0.000006986862,0.9983697,0.0001509,0.00007426718,0.0000521184,0.000523896,0.00008717406,0.00004719709,0.0006877726],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4651356,"threshold_uncertainty_score":0.9999211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2135780868","doi":"10.1056/nejmoa020798","title":"Aspirin and Mortality from Coronary Bypass Surgery","year":2002,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":677,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Texas Health Science Center at San Antonio; Karl-Franzens-Universität Graz; Rheinische Friedrich-Wilhelms-Universität Bonn; Institut de Cardiologie de Montréal; Julius-Maximilians-Universität Würzburg; Universität Heidelberg; York University; University of Arkansas for Medical Sciences; Texas Heart Institute; University of Ottawa; Thomas Jefferson University; Yale University; University of Washington; Faculty of Medicine Siriraj Hospital, Mahidol University; University of Toronto; University of Rochester; Emory University; Massachusetts General Hospital; University of Alberta; U.S. Department of Veterans Affairs","keywords":"Medicine; Aspirin; Bypass surgery; Cardiology; Surgery; Internal medicine; Coronary artery bypass surgery; Artery","retraction":null,"screen_n_in":null,"score":{"opus":0.04302693633568632,"gpt":0.2642442064293876,"spread":0.2212172700937013,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006002174,0.0001333893,0.0006738294,0.0001028964,0.00003607241,0.000006134402,0.00005341104,0.00006123305,0.001307743],"category_scores_gemma":[0.0001849736,0.00008605798,0.0001937978,0.00009125642,0.0001255384,0.00008678802,0.00001154209,0.0002371273,0.000006397146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001686187,"about_ca_system_score_gemma":0.0000507664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009863693,"about_ca_topic_score_gemma":0.000007944524,"domain_scores_codex":[0.9987079,0.0001008779,0.0004248105,0.0001225915,0.0004984938,0.0001453071],"domain_scores_gemma":[0.998863,0.0002776414,0.0001717903,0.0001793902,0.00008941631,0.0004187865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006835019,0.00009266726,0.3691636,0.00003640501,0.001155544,0.002957405,0.0003246642,0.000002585685,0.0009440762,0.00001235644,0.01881044,0.6058167],"study_design_scores_gemma":[0.04109501,0.0007323309,0.8285171,0.0006853971,0.001326633,0.005134396,0.0001400168,0.0000410001,0.0001907439,0.0004194497,0.1215732,0.0001447654],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9495364,0.04597253,0.0002223846,0.00305487,0.0004107465,0.00004780404,0.000003846192,0.00001278084,0.0007386405],"genre_scores_gemma":[0.9857899,0.008517613,0.00008856592,0.001053674,0.004217706,3.792959e-7,0.000008272033,0.000013729,0.000310188],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6056719,"threshold_uncertainty_score":0.9996052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2125043491","doi":"10.1056/nejmoa1407024","title":"Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":651,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"","keywords":"Ticagrelor; Elevation (ballistics); Myocardial infarction; Cardiology; Medicine; Internal medicine; ST segment; Acute coronary syndrome; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.008881746145355036,"gpt":0.2441208986101834,"spread":0.2352391524648284,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001130872,0.0001118799,0.0004360084,0.0002002153,0.00002362062,0.000005629222,0.00005598644,0.00005989356,0.0001652399],"category_scores_gemma":[0.0003849744,0.00007471045,0.0001511487,0.0001509182,0.00005207541,0.00009845312,0.000007862651,0.0002495322,0.000005377757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005852752,"about_ca_system_score_gemma":0.00009819351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002262744,"about_ca_topic_score_gemma":0.000003570365,"domain_scores_codex":[0.9986483,0.0001187188,0.0004325953,0.0001023407,0.0005530445,0.0001450002],"domain_scores_gemma":[0.9992773,0.00008659941,0.0001606017,0.0001327053,0.0001294487,0.0002133368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002512602,0.00013843,0.08549666,0.00004850032,0.0004884421,0.0001330075,0.0007752628,0.0001986239,0.002502073,0.0003194657,0.004035843,0.9033511],"study_design_scores_gemma":[0.1259957,0.005537419,0.5996373,0.0008217213,0.0007159744,0.001630991,0.0002794091,0.0002588933,0.000317669,0.001260246,0.2633673,0.0001773462],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831491,0.001927511,0.007821781,0.005283012,0.0006947544,0.0001665834,6.986388e-7,0.00001186187,0.0009447674],"genre_scores_gemma":[0.9925469,0.0008183725,0.0002649475,0.0006424953,0.005588188,0.000001214633,0.000008810142,0.00001205526,0.0001170293],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9031737,"threshold_uncertainty_score":0.3046604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2317139162","doi":"10.1056/nejm200006153422402","title":"Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel","year":2000,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":646,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Services and Policy Research","funders":"National Heart, Lung, and Blood Institute","keywords":"Clopidogrel; Medicine; Ticlopidine; Thrombotic thrombocytopenic purpura; Thienopyridine; Antiplatelet drug; Internal medicine; Thrombocytopenic purpura; Platelet; Surgery; Aspirin","retraction":null,"screen_n_in":null,"score":{"opus":0.01563924960165597,"gpt":0.2516326002693361,"spread":0.2359933506676802,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006925872,0.0001984892,0.0009033172,0.000114874,0.00006501683,0.00001099143,0.0001334422,0.0000819504,0.003983],"category_scores_gemma":[0.0001662503,0.000110039,0.0002255509,0.0002904513,0.00018531,0.0001267882,0.000006044648,0.0003886191,0.00002308763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005552898,"about_ca_system_score_gemma":0.0002803825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002203138,"about_ca_topic_score_gemma":0.000009327066,"domain_scores_codex":[0.9982219,0.0001253083,0.0004655096,0.0001463336,0.000787068,0.0002538727],"domain_scores_gemma":[0.9988263,0.0001274416,0.0002039521,0.0002335245,0.0001960964,0.000412722],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00704245,0.0004616521,0.02726148,0.00006460802,0.005057685,0.00450407,0.001345547,0.0002064776,0.001384853,0.0001289136,0.01700393,0.9355384],"study_design_scores_gemma":[0.3256434,0.01517553,0.4184949,0.004551127,0.005899552,0.02322493,0.0004814681,0.0000621686,0.0005168337,0.001011514,0.2044018,0.0005368439],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.981427,0.00798593,0.0002486982,0.004269203,0.000200864,0.0001788586,0.000001456976,0.00002954382,0.005658484],"genre_scores_gemma":[0.9910561,0.003211059,0.0001587451,0.0011641,0.002539793,7.715676e-7,0.00001057407,0.00002940723,0.001829484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9350015,"threshold_uncertainty_score":0.9969275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136228924","doi":"10.1056/nejmoa0908628","title":"Platelet Inhibition with Cangrelor in Patients Undergoing PCI","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":618,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital","funders":"","keywords":"Cangrelor; P2Y12; Medicine; Adenosine diphosphate; Adenosine; Conventional PCI; Platelet; Adenosine triphosphate; Pharmacology; Anesthesia; Internal medicine; Cardiology; Platelet aggregation; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.007796642200202356,"gpt":0.2269381385473938,"spread":0.2191414963471914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003601411,0.0001203817,0.0004351378,0.0002121081,0.00002510168,0.000004879951,0.00003864562,0.00004824485,0.00008025626],"category_scores_gemma":[0.0001178967,0.00007146456,0.00007934484,0.0001939298,0.00004006285,0.0001073843,0.000003092429,0.0002474003,0.000001922587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000592411,"about_ca_system_score_gemma":0.0001811643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002017289,"about_ca_topic_score_gemma":0.00002504087,"domain_scores_codex":[0.9988454,0.00005220928,0.000343283,0.00009533401,0.0005051456,0.0001586013],"domain_scores_gemma":[0.9993298,0.00005413687,0.0001587574,0.0001035974,0.0001289378,0.0002247601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01067609,0.0003249758,0.115548,0.00005167178,0.0003134237,0.002538128,0.0009202501,0.0001537692,0.0004703916,0.00009312205,0.003479718,0.8654305],"study_design_scores_gemma":[0.4257013,0.01432378,0.53771,0.003230003,0.0003936859,0.003146535,0.0002903825,0.00001223487,0.0007204998,0.0006926443,0.0135849,0.0001940486],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934598,0.001775718,0.0003784063,0.003283888,0.0001136232,0.0001277585,5.799409e-7,0.000009042673,0.0008512284],"genre_scores_gemma":[0.9966729,0.0006161378,0.0001891335,0.001203225,0.001231434,2.585973e-7,0.000009481727,0.0000100131,0.00006742311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8652364,"threshold_uncertainty_score":0.291424,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2946796958","doi":"10.1093/eurheartj/ehz372","title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Janssen Biotech; Abbott Vascular; National Institutes of Health; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Terumo; AstraZeneca; Amarin Corporation; Biotronik; Biosense Webster; Novo Nordisk; Cordis; Daiichi-Sankyo; Sanofi; Abiomed; GlaxoSmithKline; Chiesi USA; Cook Medical; Biosensors International Group; Medicure; Boston Scientific Corporation; University of Florida; Medtronic; CSL Behring; Bristol-Myers Squibb; Eli Lilly and Company; Chiesi Farmaceutici; B. Braun Melsungen; Chiesi España; Edwards Lifesciences; Amgen; Pfizer","keywords":"Medicine; Percutaneous coronary intervention; Major bleeding; MEDLINE; Severe bleeding; Surgery; Internal medicine; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.03321467043244099,"gpt":0.3160486166234949,"spread":0.2828339461910539,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005144431,0.000234205,0.0004597496,0.0001905677,0.0006797875,0.0001443008,0.0002459354,0.00009145432,0.0003635056],"category_scores_gemma":[0.0008724504,0.000177967,0.0004595819,0.0002110694,0.0001410435,0.0001347262,0.0001601836,0.002086465,0.0002234375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002475981,"about_ca_system_score_gemma":0.0001427982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001246434,"about_ca_topic_score_gemma":0.000007797897,"domain_scores_codex":[0.9955114,0.001922303,0.0007025254,0.0004251733,0.0008148951,0.0006237718],"domain_scores_gemma":[0.9970434,0.001838543,0.0002970058,0.0003304385,0.0002534856,0.00023716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002406281,0.0001132362,0.9801818,0.00005164785,0.0007951945,0.000464992,0.0007338607,0.0003473083,0.000258017,0.0001489913,0.002665997,0.01183265],"study_design_scores_gemma":[0.01121721,0.001659987,0.9742188,0.002232972,0.0004474155,0.00165116,0.003311557,0.0001552995,0.0001163553,0.0008670223,0.003834108,0.0002881323],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916425,0.005707778,0.00009454007,0.0005633006,0.0008219653,0.000755802,0.00005866704,0.00004107029,0.000314399],"genre_scores_gemma":[0.9955635,0.002489695,0.0006676582,0.000263449,0.0007189989,0.000005633683,0.00003688494,0.00007822327,0.000175963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01154452,"threshold_uncertainty_score":0.9064769,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249549775","doi":"10.1161/01.cir.0000047041.66447.29","title":"ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina—Summary Article","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Douglas College","funders":"","keywords":"Medicine; Guideline; Intensive care medicine; Angina; Internal medicine; Myocardial infarction; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.009685152932786597,"gpt":0.2333173166930585,"spread":0.2236321637602719,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001784682,0.00007419458,0.000123279,0.00002467339,0.00007071213,0.000007387718,0.00003630805,0.00002482275,0.0001803703],"category_scores_gemma":[0.000006176215,0.00004959798,0.0001040223,0.0001358481,0.0000271768,0.00007710963,0.000006266859,0.00002731637,0.000008827811],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000043949,"about_ca_system_score_gemma":0.00002997523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002085548,"about_ca_topic_score_gemma":8.324105e-7,"domain_scores_codex":[0.9993537,0.00001966364,0.0001649206,0.000125765,0.0002007195,0.0001352191],"domain_scores_gemma":[0.9994932,0.0000123373,0.0000594117,0.0002707397,0.0001317722,0.00003255301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002828023,0.001929419,0.6134892,0.002113841,0.009140321,0.000031933,0.0003199117,0.05098587,0.001666431,0.01659271,0.0131696,0.2877328],"study_design_scores_gemma":[0.008968464,0.000180711,0.8955671,0.0001538897,0.001727489,0.000004212474,0.0001385924,0.005540304,0.002104491,0.0002492461,0.08517745,0.0001880674],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9114115,0.005241049,0.08113977,0.00009159191,0.00007246033,0.001232818,0.00001705595,0.00002938014,0.0007643808],"genre_scores_gemma":[0.9985501,0.0001630399,0.0008859386,0.0001062616,0.00003599308,0.00003631592,0.00009960214,0.00001508409,0.0001076463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2875447,"threshold_uncertainty_score":0.2022547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132247347","doi":"10.1016/s1474-4422(07)70250-8","title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","year":2007,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":558,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Stroke (engine); Clopidogrel; Placebo; Aspirin; Internal medicine; Relative risk; Randomized controlled trial; Absolute risk reduction; Surgery; Anesthesia; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.03280484385702336,"gpt":0.3193459786047938,"spread":0.2865411347477704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134228,0.0001584723,0.001009928,0.00006764582,0.00004915455,0.000007988288,0.0001410003,0.00005733068,0.00004360616],"category_scores_gemma":[0.00007249963,0.00009975049,0.0002566644,0.0000896131,0.0001337869,0.00002474382,0.00003286462,0.0002492245,0.00000456342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007756107,"about_ca_system_score_gemma":0.00005471666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008405615,"about_ca_topic_score_gemma":0.000008938741,"domain_scores_codex":[0.9983667,0.000380744,0.0003962796,0.0002641512,0.0002626936,0.0003294792],"domain_scores_gemma":[0.9989379,0.0003759935,0.0001175302,0.0003865473,0.00005322044,0.0001287865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9748735,0.0004972899,0.00166019,0.00005312786,0.0007108115,0.00008742165,0.0004164171,0.00006458675,0.01027156,0.0000934424,0.00044365,0.01082802],"study_design_scores_gemma":[0.8845586,0.01364683,0.09371831,0.00005313681,0.0007869059,0.0001719396,0.0000456403,0.0002087166,0.0009500434,0.00002341073,0.005658322,0.0001781012],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897849,0.0007470144,0.002596686,0.002079438,0.0002737644,0.002999196,0.00001680273,0.00002631478,0.001475875],"genre_scores_gemma":[0.9971804,0.0002657888,0.0000753124,0.001846912,0.0003797425,0.00009859488,0.000003624672,0.00001440436,0.0001352275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09205812,"threshold_uncertainty_score":0.4067707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082043630","doi":"10.1111/jth.12231","title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH","year":2013,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":547,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"British Heart Foundation","keywords":"Standardization; Medicine; Presentation (obstetrics); Psychological intervention; Consensus conference; MEDLINE; Protocol (science); Systematic review; Computer science; Medical physics; Alternative medicine; Pathology; Surgery; Political science; Nursing; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05445597179860834,"gpt":0.2970151790106052,"spread":0.2425592072119969,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004988264,0.0001056246,0.0005329513,0.00004413025,0.0001659084,0.00001149653,0.0001562624,0.00006895851,0.0001409995],"category_scores_gemma":[0.0001037588,0.00004587185,0.0005273937,0.0002079447,0.0002057389,0.00004241442,0.00002492285,0.0001376102,1.348147e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001409727,"about_ca_system_score_gemma":0.00007530653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006806696,"about_ca_topic_score_gemma":0.000005472852,"domain_scores_codex":[0.9988303,0.000178508,0.000537667,0.00008883514,0.0002600574,0.0001046004],"domain_scores_gemma":[0.9979985,0.0006828635,0.0006925104,0.0002529571,0.0003286507,0.00004452612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003310517,0.0008627763,0.0301151,0.0004412605,0.01310422,0.000002016983,0.006749907,0.0003062089,0.1588756,0.0004429726,0.07715626,0.7086331],"study_design_scores_gemma":[0.009924126,0.001082002,0.4685574,0.002720159,0.004468984,0.00006850545,0.007339424,0.0003985458,0.3545126,0.00313809,0.1475299,0.0002603228],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645929,0.01027068,0.002993815,0.02137492,0.0001497375,0.0004712551,0.0001158353,0.000002678577,0.00002823881],"genre_scores_gemma":[0.9900829,0.008809153,0.0007600683,0.0002341337,0.00008314314,0.000005363692,0.000008290981,0.00001109747,0.000005904594],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7083728,"threshold_uncertainty_score":0.18706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3193614870","doi":"10.1056/nejmoa2108749","title":"Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk","year":2021,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":544,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Terumo","keywords":"Medicine; Conventional PCI; Cardiology; Drug-eluting stent; Antiplatelet drug; Internal medicine; Coronary stent; Percutaneous coronary intervention; P2Y12; Aspirin; Stent; Clopidogrel; Myocardial infarction; Restenosis","retraction":null,"screen_n_in":null,"score":{"opus":0.008914497911162245,"gpt":0.2305804870961671,"spread":0.2216659891850049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007493045,0.0001922854,0.0007452248,0.0001945601,0.00004753231,0.000009208802,0.00006592076,0.00009580671,0.001168276],"category_scores_gemma":[0.0002558987,0.0001259357,0.0002410369,0.0002672579,0.0000748245,0.000107741,0.00002783985,0.000420217,0.000009091137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007487128,"about_ca_system_score_gemma":0.000152943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004102243,"about_ca_topic_score_gemma":0.0000148296,"domain_scores_codex":[0.998046,0.0001866265,0.0005763487,0.000185716,0.0007487554,0.0002565538],"domain_scores_gemma":[0.9988202,0.0001214402,0.0002414776,0.0002117728,0.0002802261,0.000324811],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01018102,0.0002609393,0.7235785,0.00002995093,0.000786386,0.005115837,0.0008061946,0.00002629666,0.001121601,0.000008734288,0.002565156,0.2555194],"study_design_scores_gemma":[0.1790403,0.001748469,0.7658005,0.0006918244,0.0003781635,0.002200736,0.0001348102,0.000005913018,0.001782319,0.0001837564,0.04787571,0.0001575165],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797612,0.01767396,0.00005879869,0.001434167,0.0006914922,0.0001151233,0.000005577377,0.000009805863,0.0002498761],"genre_scores_gemma":[0.9811578,0.01441757,0.0001514689,0.0008088792,0.003127408,0.000001095925,0.00001930293,0.00002550156,0.0002909822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2553619,"threshold_uncertainty_score":0.9997448,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2082149672","doi":"10.1056/nejmoa1008410","title":"Effects of<i>CYP2C19</i>Genotype on Outcomes of Clopidogrel Treatment","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":535,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Medicines Company; Eisai; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Clopidogrel; Medicine; CYP2C19; Internal medicine; Hazard ratio; Placebo; Confidence interval; Cardiology; Gastroenterology; Myocardial infarction; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.00844415188513664,"gpt":0.265374578896807,"spread":0.2569304270116704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003792547,0.0001615467,0.0009431729,0.0001392936,0.0000192991,0.000001431965,0.0000883237,0.00007719088,0.0001316483],"category_scores_gemma":[0.000227022,0.00008555264,0.0003823547,0.0001110001,0.0001229731,0.00003009856,0.000006499869,0.0002312302,0.000002908681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001644022,"about_ca_system_score_gemma":0.0001567262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004368392,"about_ca_topic_score_gemma":0.000004356232,"domain_scores_codex":[0.9987176,0.00006072643,0.0004730201,0.00009475357,0.0005222333,0.0001316311],"domain_scores_gemma":[0.9987022,0.0003270805,0.0003200099,0.0002267996,0.0001664317,0.0002575203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006242058,0.0009194185,0.07790037,0.0003651567,0.004278219,0.001028577,0.001014907,0.00001548155,0.0935102,0.0005370462,0.001166162,0.8130224],"study_design_scores_gemma":[0.222529,0.02223594,0.5570139,0.001802017,0.004871207,0.001502579,0.0001474727,0.000006280424,0.1105921,0.0005206613,0.07855728,0.0002214777],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907094,0.006155847,0.0001472122,0.001341555,0.0008632046,0.000175942,0.000001825914,0.00000719827,0.0005977975],"genre_scores_gemma":[0.9949782,0.002595525,0.0003168729,0.0002112769,0.001614032,8.102846e-7,0.000002336292,0.00001581226,0.0002651189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8128009,"threshold_uncertainty_score":0.3488735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2951424940","doi":"10.1016/j.jcin.2019.03.034","title":"Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention","year":2019,"lang":"en","type":"review","venue":"JACC: Cardiovascular Interventions","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":531,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; Wilfrid Laurier University; Sinai Health System; University of Ottawa","funders":"Duke Clinical Research Institute; Scott R. MacKenzie Foundation; National Center for Advancing Translational Sciences; ZonMw; Janssen Research and Development; Centros de Investigación y Desarrollo, Universidad de Valparaíso; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; TherOx; Daiichi Sankyo Europe; St. Jude Medical; National Institutes of Health; Eli Lilly Canada; Amarin Corporation; OrbusNeich; Terumo; MedImmune; Janssen Pharmaceuticals; Medtronic; Novo Nordisk; Eisai; Cleveland Clinic; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Boston Scientific Corporation; Osprey Medical; Regado Biosciences; Medicines Company; Biotronik; AstraZeneca; Abbott Vascular; Boston VA Research Institute; Sanofi-Aventis Deutschland; Novartis; Belvoir Media Group; Merck KGaA; Abbott Laboratories; Bayer; Gilead Sciences; Boehringer Ingelheim; American College of Cardiology Foundation; University of Florida; Mayo Clinic; CSL Behring; Chiesi Farmaceutici; Pfizer; Icahn School of Medicine at Mount Sinai; Bristol-Myers Squibb; Eli Lilly and Company; Takeda Pharmaceutical Company; Amgen","keywords":"Prasugrel; Ticagrelor; Medicine; Percutaneous coronary intervention; Clopidogrel; P2Y12; Coronary artery disease; Intensive care medicine; Acute coronary syndrome; Conventional PCI; Guideline; Internal medicine; Aspirin; Cardiology; Myocardial infarction; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1225998420368217,"gpt":0.3508359414560361,"spread":0.2282360994192145,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0007864679,0.0008990603,0.003327574,0.0005224795,0.0001986524,0.0001042643,0.0001510683,0.0004812545,0.0001766085],"category_scores_gemma":[0.000191241,0.0007797522,0.01031245,0.0004005176,0.0000943717,0.00008072879,0.000100509,0.0003339908,0.0001099216],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001165961,"about_ca_system_score_gemma":0.0002261728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001024005,"about_ca_topic_score_gemma":0.0000157202,"domain_scores_codex":[0.9950897,0.0007605531,0.001746897,0.001267954,0.0005479378,0.0005869919],"domain_scores_gemma":[0.9977499,0.0002882044,0.0004287318,0.001081265,0.0002263492,0.0002255516],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004313632,0.0007634794,0.00004847067,0.01177999,0.01595603,0.000569001,0.00005852565,0.0001321695,0.00001806845,0.00001041294,0.0007994296,0.9694331],"study_design_scores_gemma":[0.00669297,0.003989126,0.0002146359,0.04823261,0.01383947,0.003635311,0.0002920806,0.00008056344,0.00001948664,0.000016173,0.9221419,0.0008456778],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01451293,0.9760948,0.0009114423,0.00002687655,0.001096681,0.006754547,0.0003834069,0.0001554108,0.00006383382],"genre_scores_gemma":[0.006861692,0.9864258,0.00126847,0.00004179698,0.0005212492,0.001649805,0.00253478,0.0002327783,0.000463636],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9685874,"threshold_uncertainty_score":0.999599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986579965","doi":"10.1378/chest.11-2294","title":"New Antithrombotic Drugs","year":2012,"lang":"en","type":"review","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":531,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Population Health Research Institute","funders":"Eisai; Sanofi; Bayer HealthCare; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; American College of Clinical Pharmacy; GlaxoSmithKline; Daiichi-Sankyo; McMaster University; Eli Lilly and Company; Bristol-Myers Squibb; American Society of Hematology","keywords":"Antithrombotic; Medicine; Intensive care medicine; Anticoagulant; Clinical Practice; Fibrinolytic agent; Thrombosis; Surgery; Internal medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0645347768960622,"gpt":0.3386291739302689,"spread":0.2740943970342067,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003795099,0.0003673505,0.0019516,0.0001594513,0.0001133214,0.000067879,0.0001854523,0.0002856803,0.001647318],"category_scores_gemma":[0.00002421019,0.0002491612,0.002502797,0.00019926,0.00004647624,0.0001106954,0.00003193262,0.0009065619,0.0008504009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001177527,"about_ca_system_score_gemma":0.001060887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001519496,"about_ca_topic_score_gemma":6.145284e-8,"domain_scores_codex":[0.9984045,0.000111973,0.0004678234,0.0001893635,0.0004262055,0.0004001501],"domain_scores_gemma":[0.9985023,0.00003765653,0.0002648048,0.0003790393,0.00005312841,0.000763137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008252781,0.00005052724,0.0000167212,0.008683859,0.00173103,0.0002473274,0.00003981082,3.627858e-8,1.498525e-7,0.00001740264,0.003251959,0.9859529],"study_design_scores_gemma":[0.0005947143,0.00004602932,0.00006751042,0.01104444,0.01065328,0.01253953,0.00001879893,6.472436e-8,9.286833e-7,0.00002041077,0.9647714,0.0002428706],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006808383,0.9961299,0.0006687528,0.0000314695,0.0007978506,0.0002517609,0.000003176426,0.00003814392,0.002072117],"genre_scores_gemma":[0.00001475261,0.9913706,0.0008118303,0.00007445821,0.005479356,0.000002981554,0.00003083033,0.0000847605,0.002130399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.98571,"threshold_uncertainty_score":0.9999961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1986849025","doi":"10.1161/circulationaha.107.187930","title":"2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":526,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Douglas College","funders":"","keywords":"Medicine; Angina; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.02052531482063882,"gpt":0.2671666551228319,"spread":0.2466413403021931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004092294,0.0001129716,0.0001944841,0.00004752897,0.00009421281,0.000005774479,0.0001126768,0.0000460668,0.0001012625],"category_scores_gemma":[0.00001259943,0.00006383836,0.0002282745,0.0002546081,0.00007163421,0.00007470298,0.00002209947,0.00004525031,0.000003281023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000115394,"about_ca_system_score_gemma":0.00007184729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001088596,"about_ca_topic_score_gemma":0.000006740431,"domain_scores_codex":[0.9989801,0.00001817037,0.0002775583,0.0001518735,0.0003666469,0.000205636],"domain_scores_gemma":[0.9989221,0.0000269503,0.0001701583,0.0004609062,0.0003891292,0.00003074152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002424422,0.0006516743,0.3979914,0.002906427,0.006724122,0.00001006427,0.0002450044,0.02572991,0.001500043,0.00284088,0.005952895,0.5530232],"study_design_scores_gemma":[0.004383473,0.0001210406,0.9726689,0.0002793059,0.0009463889,0.000001791673,0.00005403501,0.002214422,0.001914839,0.00004911386,0.01726133,0.0001053098],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8842382,0.01512651,0.09749413,0.0002535174,0.0002194952,0.002270228,0.00003595959,0.00002857209,0.0003334164],"genre_scores_gemma":[0.9989648,0.0002513425,0.0003530681,0.00008047022,0.0001404711,0.00002251175,0.00005516515,0.00002144634,0.0001107618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5746775,"threshold_uncertainty_score":0.2603253,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140261980","doi":"10.1093/eurheartj/ehm226","title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease","year":2007,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":524,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Aspirin; Coronary artery disease; Internal medicine; Cardiology; Platelet; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.02409134132043712,"gpt":0.2760527910791095,"spread":0.2519614497586724,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008307013,0.0001170571,0.0002793654,0.0001050192,0.00007009994,0.0000102705,0.00009868949,0.00001479319,0.00006762683],"category_scores_gemma":[0.00006058169,0.00007692964,0.0001208944,0.0001991244,0.00007407497,0.00009407846,0.0000258162,0.0002044321,0.00000903986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003009313,"about_ca_system_score_gemma":0.00005940174,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":9.899134e-7,"about_ca_topic_score_gemma":0.000009366549,"domain_scores_codex":[0.998557,0.0002015823,0.000407875,0.0001502273,0.0004698191,0.0002134924],"domain_scores_gemma":[0.9991387,0.00007081196,0.0001536221,0.0002824039,0.0001419827,0.0002125046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009824648,0.0004332486,0.9838568,0.0002221498,0.00009724881,0.000247019,0.000172808,0.00007773037,0.0004402616,0.000002432643,0.0004639521,0.004161729],"study_design_scores_gemma":[0.002462207,0.0009086709,0.992133,0.0007623614,0.0001269352,0.00005093645,0.0000524805,0.000005338846,0.0003405124,0.000003790307,0.003071143,0.00008261402],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969528,0.001863116,0.0003988034,0.00007225258,0.00006539941,0.0003417424,0.00001467064,0.000008880142,0.0002823284],"genre_scores_gemma":[0.9991604,0.00002724088,0.0002844249,0.0001972349,0.00008619206,0.000001150086,0.00000494472,0.00002287592,0.0002155489],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008276237,"threshold_uncertainty_score":0.3137099,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085190889","doi":"10.1016/j.jacc.2005.01.034","title":"Resistance to clopidogrel: A review of the evidence","year":2005,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":520,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Clopidogrel; Medicine; Platelet; Antiplatelet drug; Acute coronary syndrome; Cardiology; P2Y12; Internal medicine; Pharmacology; Aspirin; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.03852248992245044,"gpt":0.3521212645202035,"spread":0.3135987745977531,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00158224,0.0003127264,0.005953351,0.0001432032,0.00005164721,0.000001888614,0.001108792,0.0001035567,0.00001492508],"category_scores_gemma":[0.001531558,0.0001472983,0.006717432,0.001240569,0.0006728904,0.00003492691,0.0001900221,0.0005574587,0.000003433971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001546126,"about_ca_system_score_gemma":0.00151415,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001444202,"about_ca_topic_score_gemma":0.00000122193,"domain_scores_codex":[0.9955692,0.00173398,0.001503239,0.0002171122,0.0007426773,0.0002337453],"domain_scores_gemma":[0.994317,0.0005122587,0.00318988,0.001279313,0.0005698715,0.0001316961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008982198,0.00006227095,0.0003421025,0.07526649,0.008957202,0.0003143268,0.0000145563,0.00002234732,0.00001052855,0.000110463,0.1267332,0.7872683],"study_design_scores_gemma":[0.0001876054,0.000252357,0.000346291,0.186462,0.006128744,0.002899318,0.000015758,2.872738e-8,0.000004306996,0.000007485312,0.8035931,0.0001029599],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001310623,0.9954547,0.00004368067,0.002424534,0.0004299602,0.0009797136,0.000103542,0.000003729188,0.0004290715],"genre_scores_gemma":[0.0006028168,0.9963821,0.0002835221,0.001334229,0.0008403639,0.0000154245,5.732033e-7,0.00003653642,0.0005044602],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7871653,"threshold_uncertainty_score":0.677471,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4240019765","doi":"10.1016/s0140-6736(06)68040-9","title":"Aspirin resistance","year":2006,"lang":"en","type":"review","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":497,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Aspirin; Platelet; Thromboxane; Thromboxane A2; Thromboxane B2; Medicine; Platelet activation; Antiplatelet drug; Pharmacology; Thromboxane-A synthase; Thromboxane receptor; Internal medicine; Clopidogrel","retraction":null,"screen_n_in":null,"score":{"opus":0.0671959277897354,"gpt":0.3429544237355043,"spread":0.2757584959457688,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002824997,0.0002266812,0.001997401,0.00003159604,0.00006603853,0.00002168624,0.0002739355,0.0001290502,0.00007214019],"category_scores_gemma":[0.00001742905,0.0001186124,0.001017055,0.0001726972,0.00007964118,0.00001435359,0.00002994598,0.0003127536,0.000279143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003580198,"about_ca_system_score_gemma":0.0001183549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003840908,"about_ca_topic_score_gemma":0.000004263323,"domain_scores_codex":[0.9989363,0.0001422898,0.0002311847,0.0002149626,0.0002332814,0.0002419658],"domain_scores_gemma":[0.9987016,0.00005850025,0.0001026505,0.001072074,0.00002123249,0.00004398275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004138412,0.0000216835,0.000005104938,0.01303752,0.0006333066,0.0001168056,0.000003881065,1.191114e-7,3.497993e-8,0.0004334799,0.1417627,0.843944],"study_design_scores_gemma":[0.0004459308,0.00001095976,0.00004618095,0.008513322,0.001963388,0.00009056881,0.000001428389,6.866054e-8,2.886109e-7,0.0000909702,0.9887019,0.0001350145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003104386,0.9724293,0.00002143613,0.0001928716,0.000101037,0.0004637952,0.00005707773,0.00009001767,0.02664141],"genre_scores_gemma":[0.000003902258,0.9853119,0.00006006367,0.0003539462,0.002895872,0.00005356635,0.0001919093,0.00004327511,0.01108558],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8469391,"threshold_uncertainty_score":0.4836873,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116051185","doi":"10.1378/chest.11-2306","title":"Primary and Secondary Prevention of Cardiovascular Disease","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":472,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Prasugrel; Aspirin; Percutaneous coronary intervention; Antithrombotic; Ticagrelor; Coronary artery disease; Internal medicine; Conventional PCI; Acute coronary syndrome; Cardiology; Guideline; Stent; Myocardial infarction; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.01697712523490647,"gpt":0.2412518767060041,"spread":0.2242747514710977,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121954,0.00008598219,0.0002846524,0.00005358847,0.00006215624,0.00001003439,0.00003385367,0.00003855819,0.0001209651],"category_scores_gemma":[0.00002759837,0.00006963772,0.0006311685,0.00005398468,0.0000713242,0.0001961857,0.00001935559,0.0001631888,0.000004614885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002353539,"about_ca_system_score_gemma":0.0001263438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.508348e-7,"about_ca_topic_score_gemma":1.260342e-8,"domain_scores_codex":[0.9992324,0.00006718707,0.0001671978,0.00008164823,0.0002883401,0.0001632746],"domain_scores_gemma":[0.9992993,0.00001077477,0.00005581855,0.000197279,0.00005394179,0.0003829113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00105848,0.0008156932,0.1571838,0.002006894,0.01040221,0.0003111905,0.0004831738,0.00003003534,0.002053178,0.0001751533,0.0008960646,0.8245842],"study_design_scores_gemma":[0.002608251,0.000101782,0.8758785,0.0002016786,0.002494305,0.00155719,0.000115758,0.000005548954,0.001065503,0.0001625451,0.1156841,0.0001248268],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8155385,0.1811781,0.00195277,0.00004677573,0.0001218325,0.0001034278,0.000003104657,0.0000105755,0.001044875],"genre_scores_gemma":[0.9916082,0.007112004,0.0004743372,0.00007625325,0.000563111,0.000002682712,0.00001040869,0.00001416821,0.0001388533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8244593,"threshold_uncertainty_score":0.2839743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1808601199","doi":"10.1016/j.jacc.2015.06.1323","title":"Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":448,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Internal medicine; Proportional hazards model; Myocardial infarction; Incidence (geometry); Interquartile range; Population; Cardiology; Surgery; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.009565316787636596,"gpt":0.2683444677443543,"spread":0.2587791509567177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005371078,0.0001152779,0.0008870411,0.0001341696,0.00002014542,0.000002122398,0.0001316636,0.00004562259,0.00001387096],"category_scores_gemma":[0.0001705662,0.00006844227,0.001088295,0.0001749177,0.0004920932,0.00007722015,0.00005915517,0.0001660609,3.994187e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007745019,"about_ca_system_score_gemma":0.0002310887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002187639,"about_ca_topic_score_gemma":0.000001114625,"domain_scores_codex":[0.9987668,0.0002718912,0.0004302098,0.0000921001,0.0003045581,0.0001344414],"domain_scores_gemma":[0.998571,0.00006958133,0.0005659172,0.0001960858,0.000453165,0.0001442109],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01145086,0.0000772979,0.9685076,0.00006476248,0.004086528,0.001165486,0.0002026076,0.0002511614,0.01013758,0.0000117158,0.001481353,0.002563037],"study_design_scores_gemma":[0.002131491,0.008041583,0.9266376,0.0002839502,0.001199425,0.05893094,0.001772594,0.00003497986,0.0003095942,0.00009486032,0.0004633455,0.00009955535],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995061,0.004139646,0.0001041753,0.0001536191,0.0001881764,0.0001401019,0.00009199089,0.000003656055,0.0001176066],"genre_scores_gemma":[0.9989105,0.0006412304,0.0001217691,0.00005671229,0.0002112513,0.000001281731,0.000001377218,0.00001210556,0.00004376883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05776546,"threshold_uncertainty_score":0.2790995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3080963011","doi":"10.1001/jama.2020.12443","title":"Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"JAMA","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital; Université de Montréal; University of Alberta; Canadian VIGOUR Centre; University of Ottawa; Heart and Stroke Foundation; University of Toronto","funders":"Duke Clinical Research Institute; National Heart, Lung, and Blood Institute; Arts and Humanities Research Council; American Regent; Esperion Therapeutics; Servier; Novo Nordisk; Chung-Ang University; University of Toronto; Daiichi-Sankyo; Greenville Health System; NorthShore University HealthSystem; National Institutes of Health; Regeneron Pharmaceuticals; Ajou University; Amgen; Heart and Stroke Foundation of Canada; Henry Ford Health System; University of Minnesota; Aurora Research Institute; York University; Sunnybrook Research Institute; Pfizer; Sharp HealthCare; Sanofi; HLS Therapeutics; GlaxoSmithKline; NYU Langone Medical Center; CSL Behring; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Percutaneous coronary intervention; Clopidogrel; Conventional PCI; Internal medicine; Randomized controlled trial; Cardiology; Ticagrelor; Myocardial infarction; Hazard ratio; Coronary artery disease; Clinical endpoint; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.01310627546105753,"gpt":0.2754705644234851,"spread":0.2623642889624276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002085347,0.0001929984,0.0004412471,0.00005687616,0.0000376197,0.00001159701,0.00006057354,0.000135416,0.0008025358],"category_scores_gemma":[0.00007763488,0.0001479205,0.0007778489,0.0001249581,0.00005849555,0.00008038096,0.00001994287,0.0001985909,0.00009804374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004770088,"about_ca_system_score_gemma":0.00003416124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001234246,"about_ca_topic_score_gemma":7.520787e-7,"domain_scores_codex":[0.9987433,0.0001892865,0.0002864836,0.0002628764,0.0003614993,0.0001565855],"domain_scores_gemma":[0.999494,0.000065583,0.00008692564,0.0001441524,0.00009759797,0.0001118086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07162385,0.0007392596,0.6412017,0.0008493284,0.002964846,0.0005806162,0.000416617,0.00003416023,0.06356122,0.00003792784,0.007009459,0.210981],"study_design_scores_gemma":[0.0297229,0.01340379,0.765393,0.0004862358,0.0008316556,0.001056754,0.00005974465,0.0004498381,0.1630238,0.00001854091,0.02505232,0.0005013943],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968831,0.001407402,0.0001103854,0.0006738953,0.0001794091,0.0004860525,0.00001842781,0.00008226979,0.0001590727],"genre_scores_gemma":[0.997628,0.0001661524,0.00005550767,0.001426908,0.0003324592,0.00003296808,0.00009903071,0.00003104745,0.0002279323],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2104796,"threshold_uncertainty_score":0.8787205,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012343501","doi":"10.1161/circulationaha.111.029165","title":"Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Cardiology; Internal medicine; Platelet; Percutaneous; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.02078077470867695,"gpt":0.2335751729416853,"spread":0.2127943982330083,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000211224,0.0001352777,0.0003231233,0.00006792613,0.00005428596,0.00001138889,0.0000274549,0.00009862102,0.0002327601],"category_scores_gemma":[0.00002559753,0.0001217134,0.0005870324,0.00006276298,0.0000597592,0.0001635845,0.0000203987,0.00009415229,0.0000285967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003317672,"about_ca_system_score_gemma":0.000013814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005543034,"about_ca_topic_score_gemma":0.000002659298,"domain_scores_codex":[0.9991139,0.00007478936,0.0001596472,0.0002714592,0.0002421663,0.0001380482],"domain_scores_gemma":[0.9994591,0.0000139017,0.00003311186,0.000353189,0.00005111057,0.00008962022],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005328548,0.0001569902,0.8023982,0.00009192787,0.001526476,0.0008875597,0.0004449782,0.000009863307,0.0005499822,0.00004558642,0.00000856393,0.193347],"study_design_scores_gemma":[0.001154641,0.00004549896,0.9945211,0.00004860282,0.00051527,0.002183218,0.0001064938,0.0001001492,0.0002523976,0.0002143936,0.0007205299,0.0001376452],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920622,0.004578546,0.001961075,0.00001585456,0.0001018412,0.0003190131,0.000004882501,0.00008527328,0.0008712999],"genre_scores_gemma":[0.9993849,0.0001961776,0.0001804886,0.00008192346,0.0000490729,0.00002015886,0.00003248077,0.00002179534,0.00003302234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1932094,"threshold_uncertainty_score":0.4963329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105210342","doi":"10.1016/s0140-6736(15)60263-x","title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials","year":2015,"lang":"en","type":"review","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Meta-analysis; Drug-eluting stent; Internal medicine; Bayesian network; Randomized controlled trial; Stent; Pairwise comparison; Drug; Cardiology; Pharmacology; Statistics; Restenosis; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.1336524775581952,"gpt":0.3583823916000645,"spread":0.2247299140418693,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00513689,0.0004649448,0.01010447,0.0001978371,0.00005609047,0.00003963152,0.0001190124,0.0001531106,0.00009462576],"category_scores_gemma":[0.00008011976,0.0002164717,0.002480541,0.0008676282,0.00009779216,0.00007155804,0.00002450049,0.0002225702,0.000001072826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003727473,"about_ca_system_score_gemma":0.0001339821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000512429,"about_ca_topic_score_gemma":0.00003820678,"domain_scores_codex":[0.99435,0.002964145,0.001376979,0.0004270297,0.0005745899,0.0003072587],"domain_scores_gemma":[0.9975109,0.000425641,0.001035464,0.0007676812,0.000159599,0.0001007818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03693372,0.0003386064,0.01591848,0.002410535,0.660246,0.0001739593,0.0004435336,0.00009365957,2.374376e-7,0.000008073586,0.0002638962,0.2831693],"study_design_scores_gemma":[0.0550578,0.0003044583,0.0374009,0.001159351,0.8845035,0.00003983984,0.0000509805,0.00006734441,0.000003017843,0.00002232992,0.02088799,0.0005025006],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08438383,0.9120445,0.00002984185,0.00003110803,0.0000279781,0.003095719,0.0003165721,0.00002803074,0.00004240398],"genre_scores_gemma":[0.08453025,0.913422,0.00004830912,0.00009981295,0.0002639844,0.0003810394,0.001190473,0.0000380932,0.00002600306],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2826668,"threshold_uncertainty_score":0.882746,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991270018","doi":"10.1016/s0140-6736(12)60161-5","title":"Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Prasugrel; CYP2C19; Percutaneous coronary intervention; Conventional PCI; Pharmacogenetics; Internal medicine; Genotyping; Acute coronary syndrome; Prospective cohort study; Clinical endpoint; Randomized controlled trial; Aspirin; Genotype; Genetics; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.04682355574112172,"gpt":0.2899955717577107,"spread":0.243172016016589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003357622,0.0001335302,0.0007645477,0.00003483418,0.00004902178,0.000003589648,0.00008542625,0.00005174005,0.00003036874],"category_scores_gemma":[0.0001719437,0.0000819693,0.0004265364,0.0001155968,0.0001200231,0.00004921648,0.00001066559,0.0000427847,4.924032e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003244382,"about_ca_system_score_gemma":0.00008038371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001478325,"about_ca_topic_score_gemma":4.800543e-7,"domain_scores_codex":[0.9990434,0.0001089094,0.0003023446,0.0001313762,0.0002009621,0.0002130207],"domain_scores_gemma":[0.999016,0.0002141567,0.0002215484,0.0003342168,0.0001671747,0.00004687704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5629749,0.001442491,0.07719954,0.001631576,0.004499779,0.000009738321,0.01919346,0.0002456593,0.01928786,0.0003088042,0.0003591915,0.312847],"study_design_scores_gemma":[0.4910447,0.005562232,0.02595476,0.000313254,0.002144285,0.00008082506,0.001465874,0.0001879265,0.4718958,0.0001769935,0.0009472728,0.0002261464],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790788,0.01621815,0.0008759866,0.00006521177,0.000115243,0.00322367,0.00009987147,0.00001850608,0.0003045865],"genre_scores_gemma":[0.9956247,0.0001088559,0.002830997,0.00002831815,0.001118736,0.0001959235,0.00004364584,0.0000195754,0.00002930153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4526079,"threshold_uncertainty_score":0.3342611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3010522600","doi":"10.1038/s41573-020-0061-0","title":"Therapeutic strategies for thrombosis: new targets and approaches","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":387,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Antithrombotic; Medicine; Thrombosis; Intensive care medicine; Anticoagulant; Fibrinolytic agent; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09240540115367263,"gpt":0.3529825232773089,"spread":0.2605771221236363,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004570501,0.0008960755,0.005236583,0.0001072268,0.0001084156,0.0002357051,0.0002821702,0.0007350232,0.00002085514],"category_scores_gemma":[0.000091708,0.0005581042,0.003620889,0.0003349337,0.0001090083,0.0003967909,0.00007629128,0.001167064,0.00002899235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006961766,"about_ca_system_score_gemma":0.001139542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002621084,"about_ca_topic_score_gemma":0.000001992789,"domain_scores_codex":[0.9972442,0.0003138635,0.0007755244,0.0009302843,0.0003415231,0.0003945384],"domain_scores_gemma":[0.9984179,0.0001712256,0.0004050489,0.0006810707,0.00003188693,0.0002928676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003777638,0.0000581091,0.000001773857,0.06880619,0.002256943,0.00001387872,0.00007349288,9.697121e-8,2.815566e-7,0.002039575,0.00718753,0.9195244],"study_design_scores_gemma":[0.0006158944,0.00007389727,0.000005344726,0.0204419,0.0115908,0.0001024678,0.0001342157,0.000001753087,8.962252e-7,0.0004819584,0.9660197,0.000531133],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001094615,0.9924752,0.001119774,0.0002841871,0.0002766127,0.00518095,0.0001140992,0.00007873236,0.000469406],"genre_scores_gemma":[0.00002974152,0.9955356,0.000488827,0.0008755912,0.001384357,0.0004537164,0.0005707431,0.0001415202,0.0005199139],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9588322,"threshold_uncertainty_score":0.999687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2766257307","doi":"10.1161/circulationaha.117.031164","title":"International Expert Consensus on Switching Platelet P2Y <sub>12</sub> Receptor–Inhibiting Therapies","year":2017,"lang":"en","type":"review","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Cangrelor; Intensive care medicine; Clopidogrel; Modalities; P2Y12; Aspirin; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08489093925865474,"gpt":0.3453032187574225,"spread":0.2604122794987678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004621037,0.0005074278,0.001417471,0.0002802243,0.0003459176,0.0001476514,0.0002170518,0.0004389684,0.0001135965],"category_scores_gemma":[0.0002480251,0.0004363926,0.001424859,0.00007909894,0.00007664581,0.0001093824,0.00004470336,0.0004892176,0.0002210475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002540278,"about_ca_system_score_gemma":0.0002152812,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007886693,"about_ca_topic_score_gemma":8.538812e-7,"domain_scores_codex":[0.997595,0.000206151,0.0006397082,0.00062566,0.0006301468,0.0003033425],"domain_scores_gemma":[0.9982375,0.0001850049,0.0006197788,0.0006937765,0.0001266867,0.0001372464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006922122,0.00006398428,0.00004360692,0.001223658,0.001578779,0.0001007571,0.0001765418,0.000009053912,0.0003920907,0.00008634812,0.0004611935,0.9957948],"study_design_scores_gemma":[0.001059391,0.00003528178,0.0001663852,0.01585313,0.000529454,0.0003449848,0.00005228957,0.00005402837,0.0002295253,0.00003806911,0.9811741,0.0004633612],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008068928,0.9863233,0.000230813,0.0001558404,0.00112509,0.0009847677,0.00004016142,0.0001754636,0.00289566],"genre_scores_gemma":[0.0423496,0.9543176,0.00006841435,0.0001496494,0.001956537,0.00008003831,0.0009133458,0.0001159847,0.00004879999],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9953314,"threshold_uncertainty_score":0.9998088,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156506897","doi":"10.1161/circulationaha.104.502815","title":"Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention","year":2005,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trillium Health Centre","funders":"Eli Lilly and Company","keywords":"Prasugrel; Medicine; Clopidogrel; Thienopyridine; Percutaneous coronary intervention; Internal medicine; TIMI; Cardiology; Myocardial infarction; Ticlopidine; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.01820513826902215,"gpt":0.2727335766532296,"spread":0.2545284383842074,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690766,0.0002367157,0.0009460482,0.0002324442,0.00006878707,0.00001780647,0.00007856677,0.0001520415,0.0000524065],"category_scores_gemma":[0.00008616795,0.0002017599,0.0004787748,0.0002710383,0.0001925799,0.0001872222,0.00002060487,0.000208848,0.00001492344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001482427,"about_ca_system_score_gemma":0.00008215769,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004256667,"about_ca_topic_score_gemma":0.00005722719,"domain_scores_codex":[0.9980589,0.0001721093,0.0006967573,0.0003521592,0.0004798111,0.0002403183],"domain_scores_gemma":[0.9990177,0.0001084278,0.0002988121,0.0003332429,0.0001453946,0.00009647579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.233217,0.005035038,0.3037804,0.0009884583,0.002518558,0.0002945277,0.003309344,0.02466669,0.2553027,0.0008328452,0.0001477318,0.1699067],"study_design_scores_gemma":[0.4134815,0.0008202625,0.4464543,0.001821764,0.002196653,0.003041583,0.001008552,0.09449753,0.03509534,0.0001445592,0.0006069877,0.0008309808],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819064,0.003546482,0.01259665,0.0001924924,0.00008349811,0.001190994,0.00001160415,0.00007412322,0.0003977966],"genre_scores_gemma":[0.9985884,0.0002779411,0.0005322149,0.00008498801,0.0001500741,0.00003713136,0.000271958,0.000039103,0.00001822131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2202074,"threshold_uncertainty_score":0.8227529,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4297704090","doi":"10.1378/chest.11-2293","title":"Antiplatelet Drugs","year":2012,"lang":"en","type":"article","venue":"CHEST Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":377,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University","funders":"National Heart, Lung, and Blood Institute; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Intensive care medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.0151988848918061,"gpt":0.2638194747305694,"spread":0.2486205898387633,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000400625,0.0001020865,0.0002143111,0.00005915537,0.0001242658,0.00002723274,0.00005887878,0.00006167559,0.0006783713],"category_scores_gemma":[0.00002977496,0.0000768721,0.0003440822,0.00009149482,0.00004763017,0.0001939753,0.00001322819,0.0002663318,0.0002550041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003228029,"about_ca_system_score_gemma":0.00005559226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.761592e-7,"about_ca_topic_score_gemma":1.846605e-8,"domain_scores_codex":[0.9991416,0.00003586242,0.0001539161,0.00007118689,0.0002699215,0.0003275125],"domain_scores_gemma":[0.99931,0.00001574752,0.00005017199,0.0001575099,0.00005313696,0.0004134582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001146299,0.001337954,0.5137178,0.0003328982,0.003015419,0.001245961,0.003268477,0.000007644418,0.01250305,0.0008067957,0.0353425,0.4272752],"study_design_scores_gemma":[0.003507582,0.0001172071,0.2533071,0.0001163841,0.0004017742,0.014219,0.0006288733,0.000007746011,0.01098524,0.0001245403,0.7163491,0.0002354767],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9772526,0.0126097,0.0007233337,0.0003519861,0.0004471337,0.00006714086,0.000001204431,0.000039508,0.008507374],"genre_scores_gemma":[0.9949268,0.001331034,0.0005999259,0.0005830679,0.001994742,0.000001353788,0.000004714821,0.00001982444,0.0005385444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6810066,"threshold_uncertainty_score":0.7427691,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1886686547","doi":"10.1093/eurheartj/ehv443","title":"Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials","year":2015,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network","funders":"University of Toronto; Women's College Hospital; Cleveland Clinic; Heart and Stroke Foundation of Canada","keywords":"Medicine; Myocardial infarction; Aspirin; Randomized controlled trial; Subgroup analysis; Internal medicine; Meta-analysis; Cardiology; Platelet aggregation inhibitor; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1345571203722328,"gpt":0.3756723557126026,"spread":0.2411152353403698,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.02778865,0.0005198896,0.01717604,0.0007858789,0.00007213844,0.00002294634,0.0002539059,0.0001445889,0.0001123288],"category_scores_gemma":[0.0005699416,0.0002618383,0.02651707,0.001304079,0.0002043195,0.0001437774,0.00003458605,0.0004758306,0.000001099147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004890743,"about_ca_system_score_gemma":0.0007622605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003355325,"about_ca_topic_score_gemma":8.767957e-7,"domain_scores_codex":[0.9746531,0.02041082,0.002850483,0.0003771288,0.001463016,0.0002454029],"domain_scores_gemma":[0.9940673,0.001004271,0.002787997,0.0007570992,0.001260114,0.0001232019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.03290511,0.0006728765,0.0008368138,0.002240895,0.8556662,0.00004723167,0.0004184326,0.00009412646,3.220494e-7,0.000003057879,0.0001249187,0.10699],"study_design_scores_gemma":[0.1085398,0.001452859,0.008302702,0.001550391,0.8056713,0.0001786309,0.00004947746,8.90512e-7,0.000003518433,0.000008424133,0.07396452,0.0002774629],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02128066,0.9707743,0.0003936533,0.0000103919,0.0001317441,0.006914436,0.0004392733,0.000006218007,0.00004930708],"genre_scores_gemma":[0.01716851,0.9815459,0.0001560309,0.00002537037,0.0002635811,0.0001413633,0.0006039633,0.00007523792,0.00001999245],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.1067125,"threshold_uncertainty_score":0.9999834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131470908","doi":"10.1016/s0735-1097(01)01713-2","title":"Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting","year":2002,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Ticlopidine; Clopidogrel; Medicine; Tolerability; Mace; Internal medicine; Randomized controlled trial; Adverse effect; Cardiology; Percutaneous coronary intervention; Loading dose; Clinical endpoint; Anesthesia; Myocardial infarction","retraction":null,"screen_n_in":null,"score":{"opus":0.05410016393052777,"gpt":0.3095280252545188,"spread":0.2554278613239911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.001562484,0.0003360539,0.02245524,0.0005160903,0.00002670201,0.000002619325,0.0002900583,0.0001155827,0.0000327807],"category_scores_gemma":[0.000225324,0.0001586116,0.0167298,0.0009427977,0.001665257,0.0000255543,0.00007993124,0.0003675511,1.556872e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002705211,"about_ca_system_score_gemma":0.0002404416,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008237166,"about_ca_topic_score_gemma":0.000001249198,"domain_scores_codex":[0.9953076,0.001865633,0.001901214,0.000206699,0.0005390978,0.0001798163],"domain_scores_gemma":[0.9920874,0.0009242696,0.005707653,0.0006955461,0.0004872272,0.00009786155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01342301,0.00006813342,0.001124055,0.002755482,0.9743097,0.0002499983,0.00001967442,0.0001473064,0.000002355968,0.00002277809,0.0003551311,0.007522306],"study_design_scores_gemma":[0.01049554,0.000392239,0.0003025232,0.0009772155,0.9105604,0.002193273,0.0001272358,0.00001002636,0.000004182185,0.00000350995,0.0747956,0.0001382856],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007410312,0.9910151,0.0004461454,0.00009524644,0.00005743262,0.0005461705,0.0002436833,0.000002351798,0.0001835211],"genre_scores_gemma":[0.08989702,0.9090415,0.0007283097,0.00003228286,0.0001055988,0.00001616411,0.000003909892,0.00002617188,0.0001490479],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08248671,"threshold_uncertainty_score":0.9931174,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2970797239","doi":"10.1056/nejmoa1908077","title":"Ticagrelor in Patients with Stable Coronary Disease and Diabetes","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"Agence Nationale de la Recherche; AstraZeneca","keywords":"Ticagrelor; Medicine; Internal medicine; Cardiology; Diabetes mellitus; Disease; Coronary disease; Coronary heart disease; Myocardial infarction; Acute coronary syndrome; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.004135683001723299,"gpt":0.1963194579564556,"spread":0.1921837749547323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002832326,0.0001032782,0.0004128414,0.0001120876,0.00001359296,0.000004041306,0.00004182884,0.0000245955,0.0002524277],"category_scores_gemma":[0.00006976118,0.00005739537,0.00004860841,0.00009380069,0.00006432217,0.0000965519,0.000009541905,0.0001593319,0.00000331469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001867811,"about_ca_system_score_gemma":0.0001060045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005142253,"about_ca_topic_score_gemma":0.000001098828,"domain_scores_codex":[0.9990887,0.00004416241,0.0002226681,0.00009843396,0.0004013992,0.000144646],"domain_scores_gemma":[0.9992617,0.00007050631,0.00008899673,0.0001240664,0.00009274381,0.000362014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004445993,0.00009761968,0.9404319,0.00006864399,0.0002341057,0.0001782528,0.00009415794,0.00001259891,0.00005588648,0.00001514585,0.0003466561,0.05401906],"study_design_scores_gemma":[0.08083874,0.001933954,0.9102513,0.0007220551,0.0003283452,0.00004569058,0.00005120978,0.00001393764,0.00001154571,0.00008695036,0.005651202,0.00006509885],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927076,0.0057672,0.00001625389,0.001006734,0.0001128706,0.0001862896,0.000001830591,0.000004601046,0.0001966525],"genre_scores_gemma":[0.9983975,0.0004575436,0.00006496924,0.0004469709,0.0004131053,4.751213e-7,0.000007443768,0.00001231218,0.0001997334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07639275,"threshold_uncertainty_score":0.2763906,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138696762","doi":"10.1161/01.cir.103.21.2572","title":"Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention","year":2001,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":359,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mace; Percutaneous coronary intervention; Conventional PCI; Internal medicine; Myocardial infarction; Cardiology; Platelet; Loading dose; Odds ratio","retraction":null,"screen_n_in":null,"score":{"opus":0.00686730293768508,"gpt":0.2274719538592497,"spread":0.2206046509215646,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002090158,0.0001562915,0.0003742294,0.0001202592,0.000047528,0.000004771833,0.00003032896,0.0001222802,0.00011423],"category_scores_gemma":[0.00003175127,0.0001394469,0.0004652345,0.0001802228,0.00008068161,0.0002050005,0.000009617824,0.0001160178,0.000006456149],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009196081,"about_ca_system_score_gemma":0.0000504118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003908354,"about_ca_topic_score_gemma":0.00000931367,"domain_scores_codex":[0.9986802,0.0001933166,0.000346363,0.0002538482,0.0003903291,0.0001359773],"domain_scores_gemma":[0.9990464,0.00001944023,0.000218474,0.0003228046,0.0003042987,0.00008859982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02088299,0.0009040853,0.7248559,0.0007780168,0.002415305,0.001012193,0.004372673,0.009693169,0.0458729,0.00003172649,0.00001141346,0.1891696],"study_design_scores_gemma":[0.003358009,0.0008542523,0.9812869,0.000884384,0.001369917,0.001238851,0.002269159,0.0009607619,0.007402438,0.00008744729,0.00006909435,0.00021883],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995303,0.002563521,0.001185368,0.00000989108,0.0001031496,0.0006447016,0.00004007376,0.00005126714,0.00009896847],"genre_scores_gemma":[0.9989591,0.000244524,0.0001431425,0.00001113482,0.00006322863,0.0000242198,0.0005156095,0.00002933274,0.000009713534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.256431,"threshold_uncertainty_score":0.5686478,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987027612","doi":"10.1161/01.cir.0000051362.96946.15","title":"Early and Late Effects of Clopidogrel in Patients With Acute Coronary Syndromes","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; McMaster University; Heart and Stroke Foundation of Canada; Sanofi; Hamilton Health Sciences; Bristol-Myers Squibb","keywords":"Medicine; Clopidogrel; Relative risk; Aspirin; Myocardial infarction; Internal medicine; Placebo; Refractory (planetary science); Cardiology; Acute coronary syndrome; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.004472699976012706,"gpt":0.2013304100661645,"spread":0.1968577100901518,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004400401,0.00006131486,0.000160373,0.00005238211,0.00001520995,0.000002975922,0.00001067796,0.00003859928,0.000006205571],"category_scores_gemma":[0.00001171219,0.00005039201,0.00004036315,0.00009650384,0.00003150696,0.00006652244,0.000002876579,0.00003669427,0.000001676103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001252357,"about_ca_system_score_gemma":0.00001747567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000374921,"about_ca_topic_score_gemma":2.558771e-7,"domain_scores_codex":[0.9995694,0.00003721535,0.00008593934,0.0001047054,0.0001301589,0.00007264924],"domain_scores_gemma":[0.9997829,0.00001709955,0.00003198969,0.0001015611,0.00003139137,0.00003501067],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001580985,0.00007624213,0.9942247,0.00008757998,0.0002106257,0.00004254765,0.00008930309,0.00002088997,0.0002262364,0.00009142802,6.620143e-7,0.004771711],"study_design_scores_gemma":[0.003787316,0.0001645893,0.995364,0.000118888,0.0001678692,0.00001731684,0.00000364692,0.00001572427,0.000202618,0.00008499588,0.00001705173,0.00005604879],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986269,0.000761403,0.0001532146,0.000003908656,0.00002683929,0.0003164117,0.000001105665,0.0000107851,0.00009944222],"genre_scores_gemma":[0.9998123,0.00005805558,0.00006203067,0.00002242841,0.000003711763,0.000005158838,0.00001804159,0.000008890137,0.000009358085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004715662,"threshold_uncertainty_score":0.2054926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}